Andrew Saik insider trades
Open-market stock purchases and sales by Andrew Saik, Chief Financial Officer at Arvinas, Inc, from SEC Form 4 filings since Aug 18, 2014.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | ARVN Arvinas, Inc | Sold | $46.5K |
| Jun 10, 2026 | MIST Milestone Pharmaceuticals Inc | Bought (not open market) | — |
| May 11, 2026 | ARVN Arvinas, Inc | Sold | $111K |
| Feb 26, 2026 | ARVN Arvinas, Inc | Bought (not open market) | — |
| Feb 26, 2026 | ARVN Arvinas, Inc | Bought (not open market) | — |
| Feb 13, 2026 | ARVN Arvinas, Inc | Sold | $61K |
Companies traded
- ARVN Arvinas, Inc: 4 sales, last Jun 24, 2026
- MIST Milestone Pharmaceuticals Inc: other filings, last Jun 10, 2026
- ICPT Intercept Pharmaceuticals, Inc: other filings, last Nov 8, 2023
- VYNE VYNE Therapeutics Inc: 1 buy, last May 28, 2021
- MNLO Menlo Therapeutics Inc: other filings, last May 6, 2020
- PDSB PDS Biotechnology Corp: other filings, last Feb 14, 2020
- EDGE Edge Therapeutics, Inc: other filings, last Aug 14, 2018
- AUXL Auxilium Pharmaceuticals Inc: other filings, last Jan 29, 2015